<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04307836</url>
  </required_header>
  <id_info>
    <org_study_id>DN_P101</org_study_id>
    <nct_id>NCT04307836</nct_id>
  </id_info>
  <brief_title>DENEX Renal Denervation in Patients With Hypertension on no or 1-3 Antihypertensive Medications (DENEX HTN-KORAS)</brief_title>
  <official_title>A Prospective, Multicenter, No-treatment Controlled, Randomized, Open-label, Pivotal Study to Evaluate the Safety and Efficacy of DENEX, Renal Denervation Therapy, in Patients With Hypertension on no or 1-3 Antihypertensive Medications</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Handok Kalos Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Handok Kalos Medical</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to show that the safety and efficacy of renal denervation
      using DENEX, are superior to those of control group for the patients with hypertension on no
      or 1 to 3 antihypertensive medications.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      DENEX system developed by Handok Kalos Medical Inc. is a renal denervation system to
      efficiently block the sympathetic nerve of the kidney with minimal invasive procedure. It was
      developed to block the sympathetic nerves distributed in blood vessel wall by delivering high
      frequency energy to the renal artery for the purpose of treating hypertension.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 9, 2020</start_date>
  <completion_date type="Anticipated">January 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in average daytime ambulatory systolic blood pressure at 3 months</measure>
    <time_frame>from baseline at 3 months after the procedure</time_frame>
    <description>Changes in average daytime ambulatory systolic blood pressure from baseline at 3 months after the procedure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in average 24hr ambulatory systolic blood pressure and diastolic blood pressure at 3, 6 and 12 months</measure>
    <time_frame>from baseline at 3, 6 and 12 months after the procedure</time_frame>
    <description>Changes in average 24hr ambulatory systolic blood pressure and diastolic blood pressure from baseline at 3, 6 and 12 months after the procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in average office systolic blood pressure and diastolic blood pressure at 1, 3, 6 and 12 months</measure>
    <time_frame>from baseline at 1, 3, 6 and 12 months after the procedure</time_frame>
    <description>Changes in average office systolic blood pressure and diastolic blood pressure from baseline at 1,3, 6 and 12 months after the procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in average daytime and nighttime ambulatory systolic blood pressure and diastolic blood pressure at 3, 6 and 12 months</measure>
    <time_frame>from baseline at 3, 6 and 12 months after the procedure</time_frame>
    <description>Changes in average daytime and nighttime ambulatory systolic blood pressure and diastolic blood pressure from baseline at 3, 6 and 12 months after the procedure</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Hypertension</condition>
  <condition>Vascular Diseases</condition>
  <condition>Cardiovascular Diseases</condition>
  <arm_group>
    <arm_group_label>DENEX Renal denervation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects are treated with the renal denervation procedure after randomization and maintained baseline anti-hypertensive medications</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Subjects are not treated with the renal denervation, not sham, after randomization and maintained baseline anti-hypertensive medications</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Renal Denervation</intervention_name>
    <description>Renal Denervation: DENEX system</description>
    <arm_group_label>DENEX Renal denervation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject aged 19 to 75 years old

          -  Subject should maintain the 0 to 3 antihypertensive medications of different classes,
             ACE-I, ARB, beta blocker, CCB or diuretics, without change for at least 4 weeks of
             run-in period between primary screening and secondary screening and for at least 3
             months after the procedure

          -  Subject with 140 mmHg ≤ average office SBP &lt; 180 mmHg and 90 mmHg ≤ office DBP &lt; 120
             mmHg at primary and secondary screening

          -  Subject with 135 mmHg ≤ average daytime ambulatory SBP &lt;170 mmHg and 85 mmHg ≤ average
             daytime ambulatory DBP &lt; 105 mmHg at secondary screening after the run-in period for
             at least 4 weeks

        Exclusion Criteria:

          -  Subject with the anatomical findings in kidney or renal artery which preclude renal
             denervation

          -  Subject with type 1 diabetes mellitus or uncontrolled type 2 diabetes mellitus

          -  Subject with eGFR less than 40mL/min/1.73㎡

          -  Subject with a brachial circumference greater than 42 cm.

          -  Subject with secondary hypertension (except for sleep apnea patients)

          -  Subject with a medical history of cerebrovascular disease or severe cardiovascular
             disease within 12 months prior to obtaining the consent or patients newly diagnosed
             with such diseases before enrollment.

          -  Subject rehospitalized two or more times for hypertensive crisis within 12 months
             prior to obtaining consent or hospitalized for hypertensive crisis within three months
             prior to obtaining consent.

          -  Subject with chronic oxygen therapy or mechanical ventilation (except for sleep apnea)

          -  Subject with primary pulmonary hypertension
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ki Yuk Chang, MD, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul St. Mary's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hyungsun Kim</last_name>
    <phone>+82-2-527-5498</phone>
    <email>hyungsun.kim@kalosmedical.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jae Hyung Park, Ph. D</last_name>
    <phone>+82-2-527-5375</phone>
    <email>Jaehyung.park@kalosmedical.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Bucheon St.Mary's Hospital</name>
      <address>
        <city>Bucheon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sang Hyun Ihm, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Korea University Anam Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>02841</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Soon Jun Hong, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>03080</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hae-young Lee, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Severance Hospital, Yonsei University Health System</name>
      <address>
        <city>Seoul</city>
        <zip>03722</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Byeong-Keuk Kim, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gangnam Severance Hospital, Yonsei University Health System</name>
      <address>
        <city>Seoul</city>
        <zip>06273</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Young Won Yoon, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Asan Medical Center</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pil Hyung Lee, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hanyang University Seoul Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jin Ho Shin, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Seoul St. Mary's Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ki Yuk Chang, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>March 11, 2020</study_first_submitted>
  <study_first_submitted_qc>March 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 13, 2020</study_first_posted>
  <last_update_submitted>July 20, 2020</last_update_submitted>
  <last_update_submitted_qc>July 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hypertension</keyword>
  <keyword>Renal Denervation</keyword>
  <keyword>Uncontrolled hypertension</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Vascular Diseases</mesh_term>
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

